1. Ocular blood flow biomarkers may predict long-term glaucoma progression.
- Author
-
Verticchio Vercellin AC, Harris A, Oddone F, Siesky B, Eckert G, Belamkar A, Antman G, and Segev F
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Blood Flow Velocity physiology, Nerve Fibers pathology, Follow-Up Studies, Retinal Ganglion Cells pathology, Laser-Doppler Flowmetry, Visual Field Tests, Capillaries pathology, Capillaries physiopathology, Capillaries diagnostic imaging, Disease Progression, Glaucoma, Open-Angle physiopathology, Glaucoma, Open-Angle diagnosis, Tomography, Optical Coherence methods, Intraocular Pressure physiology, Visual Fields physiology, Regional Blood Flow physiology, Retinal Vessels diagnostic imaging, Retinal Vessels physiopathology, Retinal Vessels pathology, Biomarkers blood
- Abstract
Background/aim: To examine the relationship between baseline blood flow biomarkers and long-term open-angle glaucoma (OAG) progression., Methods: 112 patients with early to moderate OAG (mean age 64.9±11.0 years; 68 female) were evaluated at baseline and every 6 months from 2008 to 2013. Biomarkers of retinal capillary blood flow were assessed by Heidelberg retinal flowmetry. Functional disease progression was monitored via Humphrey visual field examinations, defined as two consecutive visits with a mean deviation decrease ≥2 decibels and/or Advanced Glaucoma Intervention Study score increase ≥2 compared with baseline. Structural progression was monitored with optical coherence tomography and Heidelberg retinal tomograph, defined as two consecutive visits with retinal nerve fibre layer thickness decrease ≥8% and/or horizontal or vertical cup/disk ratio increase ≥0.2 compared with baseline. Mixed-model analysis of covariance was used to test for significant change from baseline to 5-year follow-up. Times to functional and structural progression were analysed using Cox proportional hazards models., Results: Lower HRF retinal capillary blood flow in the superior retina was significantly associated with structural progression (p=0.0009)., Conclusion: In our OAG sample, baseline lower retinal capillary perfusion in the superior retina was predictive of structural progression after 5 years., Trial Registration Number: NCT01145911., Competing Interests: Competing interests: There are no competing interests. Professor Alon Harris would like to disclose that he received remuneration from AdOM, Qlaris, Cipla for serving as a consultant, and he serves on the board of AdOM and Qlaris. Professor Alon Harris holds an ownership interest in AdOM, Oxymap, Qlaris and SlitLed. All relationships listed above are pursuant to Icahn School of Medicine’s policy on outside activities. The contribution of the author Francesco Oddone was supported by Fondazione Roma and by the Italian Ministry of Health. None of the other authors listed have any financial disclosures., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF